Navigation Links
Jvion Releases Five Biggest Lessons in ICD10 Documentation Success
Date:12/30/2013

Atlanta, GA (PRWEB) December 30, 2013

Atlanta-based Jvion—a healthcare technology company providing solutions to reduce clinical and financial waste—recently released their latest whitepaper “Measure Twice, Cut Once: 5 Biggest Lessons in ICD-10 Documentation Success.” The resource was developed as a roadmap for providers who face the daunting challenge of updating documentation practices as part of the transition to the new ICD-10 code set.

Jvion explains that the ICD-10 transition provides a unique chance to examine and improve documentation processes. But many providers are not able to capitalize on this opportunity because of resource, time, and budgetary constraints. To address these gaps and the pitfalls inherent to the ICD-10 transition, Jvion proposes a documentation approach based on the adage “measure twice, cut once.”

The foundation of the five steps outlined in the whitepaper is a data-driven understanding of ICD-10 documentation risks. By looking into historical claims data with the right analytic lens, a provider can analyze past coding and reimbursement details, and then translate that data into ICD-10. Critical to this analysis is a detailed view that drives down to the practitioners and coders who are documenting, understanding, coding, and communicating what is going on at the patient encounter level. The results help providers isolate the 10-20% of all charts that require real focused attention and a detailed analysis of documentation practices.

Once a provider has this analytic, measured view into ICD-10 documentation risks, they can prioritize all efforts by risk, isolate what can be fixed today in the ICD-9 world, and drive continual improvement across the conversion timeline. As the author points out, this approach has yielded thousands in savings and has helped the providers who have taken this path to drive a data-driven mindset into the entire ICD-10 conversion.

For more information or to download a copy of the whitepaper “Measure Twice, Cut Once: 5 Biggest Lessons in ICD-10 Documentation Success,” please visit Jvion at jvion.com.

About Jvion
Jvion is a healthcare technology company addressing the financial and operational impacts resulting from mandated reforms and compliance activities. We offer a suite of Big Data-enabled software solutions to: reduce the financial impact and burden of the ICD-10 conversion; and help providers protect their revenues by identifying and predicting clinical and financial waste areas.

Jvion’s solutions are powered by our proprietary Bonobo Big Data Platform, which detects otherwise hidden patterns of risk. It is through these predictive modeling capabilities that we help hospitals reduce losses affordably and in a patient-centered way.
###

Read the full story at http://www.prweb.com/releases/ICD10/Documentation/prweb11445789.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. University of California Irvine, Medical Center Selects Jvion as their ICD-10 Risk Assessment and Crosswalk Provider
2. Jvion Launches The ICD-10 Knowledge Exchange on Google+
3. Jvion Examines How Applying Smarter Technology Delivers Smarter Clinical Documentation
4. AGA releases first independently developed ABIM-approved Practice Improvement Module in GI
5. Markle releases new resources for health information sharing implementation
6. ASCO releases studies from upcoming annual meeting
7. Boys Town Releases 5 Signs of Heat Stroke in Kids
8. MTSS-mba Membership Benefits Administration Software for Private and Taft-Hartley Employee Benefit Funds Releases New Pension Modules
9. Muscular Development Store Releases the Optimum Performance Workout for High Intensity Training
10. Premier global health journal, The Lancet, releases series on universal health coverage
11. Institute for Population Health Improvement releases buyers guide for health information exchange
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... ... February 27, 2017 , ... ... last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count exceeds ... 2014. The company had 800 customers and 2,250 RCEs at the time of ...
(Date:2/26/2017)... ... February 25, 2017 , ... The February 13, 2017, assassination of Kim ... over nerve agents and the deadly use of chemical weapons. Many questions exist about ... even small doses can be lethal. , Jay Jagannathan, M.D., of Michigan-based Jagannathan Neurosurgical ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a new ... B2B Sellers will now only pay for B.A.N.T. quality sales leads based on the ... said, “Given the new reality that B2B buyers are controlling the sales process via ...
(Date:2/25/2017)... Viejo, CA (PRWEB) , ... February 25, 2017 , ... ... with ProSharpen Color tools from Pixel Film Studios. With ProSharpen Color users have total ... sliders to easily refine their color range. With color spectrum tools users can visually ...
(Date:2/24/2017)... ... February 24, 2017 , ... An in-depth computational analysis of genetic variants implicated ... to eight genes that may explain why susceptibility to one of the disorders could ... study published today in the journal npj Schizophrenia. , “There is a wealth ...
Breaking Medicine News(10 mins):
(Date:2/27/2017)...  International Biophysics Corporation, a global medical device manufacturer based ... 34% revenue growth in 2016 when compared to the previous ... growth was fueled by its AffloVest® sales in ... of its global sales of surgical product lines. ... enter our 25 th year in delivering high-quality, innovative ...
(Date:2/27/2017)... , Feb. 27, 2017  RegeneRx Biopharmaceuticals, ... clinical-stage drug development company focused on tissue protection, ... for RGN-137, GtreeBNT Co., Ltd., received a positive ... 3 clinical trial design for RGN-137 to treat ... healing gel that incorporates Thymosin beta 4 ("Tß4") ...
(Date:2/27/2017)... Leading Countries, Technologies and Companies The global ... CAGR of 8.9% from 2016-2021 and CAGR of 9.2% from 2021-2027. ... from 2016 to 2027. The market is estimated at $816m in ... ... to discover how you can exploit the future business opportunities emerging ...
Breaking Medicine Technology: